PAPER Domene-Serrano I, Cuadros R, García-Escudero V, Vallejo-Bedia F, Santa-María I, Vallés-Saiz L, Hernandez F, Avila J

Shapeshifter W-Tau Peptide Inhibits Tau Aggregation and Disintegrates Paired Helical Filaments.

Biochemistry. 2025 Mar 26; Epub 2025 Mar 26 PubMed.

PAPER Sun B, Li L, Harris OA, Luo J

Blood-brain barrier disruption: a pervasive driver and mechanistic link between traumatic brain injury and Alzheimer's disease.

Transl Neurodegener. 2025 Mar 26;14(1):16. PubMed.

PAPER Wang KS, Smeyers J, Eggan K, Budnik B, Mordes DA

C9ORF72 poly-PR disrupts expression of ALS/FTD-implicated STMN2 through SRSF7.

Acta Neuropathol Commun. 2025 Mar 26;13(1):67. PubMed.

PAPER Grande G, Valletta M, Rizzuto D, Xia X, Qiu C, Orsini N, Dale M, Andersson S, Fredolini C, Winblad B, Laukka EJ, Fratiglioni L, Vetrano DL

Blood-based biomarkers of Alzheimer's disease and incident dementia in the community.

Nat Med. 2025 Mar 26; Epub 2025 Mar 26 PubMed.

PAPER Megat S, Marques C, Hernán-Godoy M, Sellier C, Stuart-Lopez G, Dirrig-Grosch S, Gorin C, Brunet A, Fischer M, Keime C, Kessler P, Mendoza-Parra MA, Zwamborn RA, Veldink JH, Scholz SW, Ferrucci L, Ludolph A, Traynor B, Chio A, Dupuis L, Rouaux C

CREB3 gain of function variants protect against ALS.

Nat Commun. 2025 Mar 26;16(1):2942. PubMed.

PAPER Suloh H, Ojha SK, Kartawy M, Hamoudi W, Tripathi MK, Bazbaz W, Schottlender N, Ashery U, Khaliulin I, Amal H

Shared early molecular mechanisms revealed in P301S and 5xFAD Alzheimer's disease mouse models.

Transl Psychiatry. 2025 Mar 26;15(1):97. PubMed.

PAPER Buchert R, Drzezga A, Schreckenberger M, Meyer PT, Working Group Nuclear Brain Imaging of the German Society of Nuclear Medicine (DGN e.V.)

Capacity for brain amyloid PET in Germany: Results from the 1st survey on nuclear brain imaging in Germany.

Eur J Nucl Med Mol Imaging. 2025 Mar 27; Epub 2025 Mar 27 PubMed.

PAPER Cheerie D, Meserve MM, Beijer D, Kaiwar C, Newton L, Taylor Tavares AL, Verran AS, Sherrill E, Leonard S, Sanders SJ, Blake E, Elkhateeb N, Gandhi A, Liang NS, Morgan JT, Verwillow A, Verheijen J, Giles A, Williams S, Chopra M, Croft L, Dafsari HS, Davidson AE, Friedman J, Gregor A, Haque B, Lechner R, Montgomery KA, Ryten M, Schober E, Siegel G, Sullivan PJ, Whittle EF, Zardetto B, Yu TW, Synofzik M, Aartsma-Rus A, Costain G, Lauffer MC, N=1 Collaborative

Consensus guidelines for assessing eligibility of pathogenic DNA variants for antisense oligonucleotide treatments.

Am J Hum Genet. 2025 Mar 21; Epub 2025 Mar 21 PubMed.

PAPER Toraih EA, Siddiqui S, Siddiqui S, Shirini K, Elfezzani N, Abdelmaksoud A, Elshazli RM, Hussein MH, Elmorsy EM, Fawzy MS

Thyroid Disorders as a Risk Factor for Neurodegenerative Proteinopathies: A Large-Scale Propensity Score-Matched Analysis.

Neuroepidemiology. 2025 Mar 26;:1-19. Epub 2025 Mar 26 PubMed.

PAPER Aggarwal R, Kumar P, Kumar S, Tiwari S, Chaturvedi RK

Synthesis and biological evaluation of novel Trifluoromethylated Arylidene-hydrazinyl-thiazoles as neuroprotective agents.

Bioorg Chem. 2025 Mar 19;159:108390. Epub 2025 Mar 19 PubMed.

PAPER Walsh AE, Lukens JR

Harnessing microglia-based cell therapies for the treatment of neurodegenerative diseases.

Curr Opin Immunol. 2025 Mar 25;94:102552. Epub 2025 Mar 25 PubMed.

PAPER Desai P, Bond J, Dhana A, Ng TK, Krueger KR, Dhana K, Liu X, Evans DA, Rajan KB

The Social Vulnerability Index and Incidence of Alzheimer Disease in a Population-Based Sample of Older Adults.

Neurology. 2025 Apr 22;104(8):e213464. Epub 2025 Mar 26 PubMed.

PAPER Howard KA, Massimo LM, Witrick B, Zhang L, Griffin SF, Ross LA, Rennert L

Investigation of risk of Alzheimer's disease diagnosis and survival based on variation to life experiences used to operationalize cognitive reserve.

J Alzheimers Dis. 2025 Mar 26;:13872877251326818. Epub 2025 Mar 26 PubMed.

PAPER Sillapakong P, Wakabayashi T, Suzuki K

Naturido alleviates amyloid β1-42-induced adverse effects in a transgenic Caenorhabditis elegans model of Alzheimer's disease.

PLoS One. 2025;20(3):e0320636. Epub 2025 Mar 26 PubMed.

PAPER Cao F, Zhang P, Chi Y, Wang Y, Xu L, Zhang D

Celastrol Ameliorated Alzheimer's Disease in Mice by Enhancing TBX21/TREM2 Expression in Microglia and Inhibiting Tau Phosphorylation.

Neurochem Res. 2025 Mar 26;50(2):126. PubMed.